New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...
It's a decision no woman wants to have to make, but new research shows that young breast cancer patients with high-ris ...
The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients ...
To be eligible for the trial, patients were required to have stage 1 to 3 triple-negative or BRCA-mutated, hormone receptor ...